"New patent filed for the combination of EmtinB® and leading Multiple Sclerosis(MS) drug Copaxone®: MS is a complex neurological disease characterised by deterioration of the myelin sheath. An in-vitro study has reported that acombination of EmtinB® and Copaxone® has been shown to produce new myelin" - This is good news. - "Updated Atlas of MS Shows Over 2.8 Million People Worldwide Have Multiple Sclerosis -- with Nearly 1 Million in the US" (Sept 2020 )
- Forums
- ASX - By Stock
- NSB
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-3
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.784M |
Open | High | Low | Value | Volume |
4.0¢ | 4.0¢ | 4.0¢ | $698 | 17.44K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 3.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.0¢ | 32116 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 0.038 |
2 | 250000 | 0.037 |
1 | 90000 | 0.036 |
3 | 320000 | 0.035 |
1 | 100000 | 0.034 |
Price($) | Vol. | No. |
---|---|---|
0.040 | 32116 | 1 |
0.041 | 53500 | 2 |
0.042 | 138333 | 3 |
0.043 | 240000 | 2 |
0.044 | 300000 | 1 |
Last trade - 15.46pm 15/10/2024 (20 minute delay) ? |
Featured News
NSB (ASX) Chart |
The Watchlist
JBY
JAMES BAY MINERALS LIMITED
Andrew Dornan, Executive Director
Andrew Dornan
Executive Director
SPONSORED BY The Market Online